Charcoal: all 34 studies that test it
Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.
- AST-120 (Kremezin®) for the Renal Protection and Attenuation of Decline in Acute Kidney DiseaseRecruitingNCT07182422Phase 4
- Activated Charcoal Use in Chronic Kidney Disease PatientsRecruitingNCT06906874Phase 2
- The Effect of Probiotics vs Activated Charcoal in the Management of CKD Patients Suffering From Uremic Pruritus.Not yet recruitingNCT06579066Phase 2
- Activated CHARcoal in Poisoned Patient - Pilot TrialRecruitingNCT05471479Phase 4
- Does a Soft Drink Mixture Improve Tolerance of Activated Charcoal in the Adult Poisoned Patient Without Affecting EfficacyCompletedNCT06219967Phase 4Results posted
- A Pilot Feasibility Study of Activated Charcoal in Healthy VolunteersCompletedNCT04204772Early Phase 1Results posted
- Evaluation of Oral Activated Charcoal on Antimalarial Drug's Ability to Kill Parasites in Malian Children With MalariaCompletedNCT01955382Phase 2Results posted
- A Study to Evaluate the Effect of Activated Charcoal on the Absorption of LY2216684 in Healthy SubjectsCompletedNCT01389752Phase 1Results posted
- Phenytoin and Multidose Activated CharcoalCompletedNCT00823264Not applicableResults posted
- A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2)CompletedNCT00501046Phase 3Results posted
- A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1)CompletedNCT00500682Phase 3Results posted
- Evaluation of Protective Effect of Activated Charcoal and Probiotic Against Progression of Chronic Kidney DiseaseStatus unknownNCT05540431Phase 2/3
- Effects of CharcoCaps® (Activated Charcoal) vs. Placebo on Intestinal Gas ProductionCompletedNCT05510778Not applicable
- Charcoal in Lung Cancer Patients Undergoing TEMLAWithdrawnNCT04928950Phase 2
- Non Inferiority Study of a Reduced Dose of Activated Charcoal on Rivaroxaban Pharmacokinetics.CompletedNCT04767776Phase 1
- AST-120 in Hemodialysis Patients With Uremic PruritusCompletedNCT04639674Phase 4
- Role of Activated Charcoal in Decreasing Blood Urea, Creatinine and PhosphorousStatus unknownNCT04311645Phase 2
- Activates Charcoal for Patients Undergoing Invasive Procedure Delayed Due to Direct Oral AnticoagulantsWithdrawnNCT02969746Phase 4
- Pharmacokinetic Study of ASP1517 With Kremezin®CompletedNCT02693613Phase 1
- Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple SclerosisCompletedNCT01863888Phase 3
- Effect of An Oral Absorbent AST-120 in Late-stage Chronic Kidney Disease (CKD) Patients.CompletedNCT01681303Phase 4
- Effect of Replacement Volume of Haemodiafiltration and AST-120 on Toxins, Oxidative Stress and MicroInflammationCompletedNCT01458652Phase 4
- A Study on The Effect of Multiple Doses of Activated Charcoal on The Pharmacokinetics of a Single Dose of RO4995819CompletedNCT01409369Phase 1
- The Effects of AST-120 on Endothelial Dysfunction in Patients With Chronic Kidney DiseaseStatus unknownNCT01157260Phase 4
- AST-120 Used to Treat Mild Hepatic EncephalopathyCompletedNCT00867698Phase 2
- Kremezin Study Against Renal Disease Progression in KoreaCompletedNCT00860431Phase 4
- Drug-Drug Interaction Study of TRK-100STPCompletedNCT00719758Phase 1
- Safety and Efficacy of AST-120 in Patients With GERD Who Continue to be Symptomatic on a Standard Dose of PPITerminatedNCT00587275Phase 2
- Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory PouchitisTerminatedNCT00583531Phase 2
- Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel SyndromeCompletedNCT00583128Phase 2
- Safety and Efficacy of AST-120 in the Treatment of PouchitisCompletedNCT00583076Phase 2
- Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic EncephalopathyCompletedNCT00558038Phase 2
- Carbonaceous Oral Adsorbent's Effects on Progression of Chronic Kidney DiseaseCompletedNCT00456859Phase 4
- Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With FistulasCompletedNCT00321412Phase 3